Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo (Q34044910)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo |
scientific article |
Statements
1 reference
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo (English)
1 reference
D Sommermeyer
1 reference
P L Kosasih
1 reference
T Gogishvili
1 reference
D G Maloney
1 reference
C J Turtle
1 reference
S R Riddell
1 reference
15 September 2015
1 reference
1 reference
30
1 reference
492-500
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference